DNA probe-based diagnostic industry analysis
Pathogenic microorganisms such as viruses, bacteria, parasites, or fungi are harmful to health and can cause infectious diseases. The development of different DNA diagnostic probes depends on the emergence of these new infectious diseases. Technavio’s market research report identifies that the emergence of such new infectious diseases will be one of the primary growth drivers for the global DNA probe-based diagnostic market till 2021.
It has been observed that more than 100 probes have been developed, while, others are still in the experimental stages. The development of DNA probe test used to detect bacterial infections caused by Salmonella typhi (food poisoning), Escherichia coli (gastroenteritis), and Campylobacter hyointestinalis is also increasing due to the increase in infectious diseases. Technavio’s market research analysts predict that this market will grow at a CAGR of almost 11% by 2021.
DNA probe-based diagnostic market trends
Infections such as vaginitis, discharge, itching, and pain results from the overgrowth of specific organisms. The adoption of DNA probe-based technologies is increasing with the rising awareness about such infections. The increasing prominence of DNA probe technology in diagnosing vaginitis is identified as one of the key trends that will gain traction in the global DNA probe-based diagnostic market during the estimated period. Based on genetic fingerprints, DNA probes technology identifies the target organisms.
DNA probe-based diagnostic market growth: Competitive landscape and key vendors
The DNA probe-based diagnostic market comprises of diversified international and regional local vendors. These vendors are increasingly competing against each other based on factors such as the quality, price, and market reach. Furthermore, factors such as product innovations, product or service extensions, and mergers and acquisitions will strengthen the competitive environment of the DNA probe test market.
Key vendors in the DNA probe-based diagnostic market
- Abbott Laboratories
- F. Hoffmann La Roche
- GE Healthcare
- Thermo Fisher Scientific
DNA probe-based diagnostic market forecast based on application
- Infectious disease testing
- Cancer testing
The infectious disease testing segment is witnessing growth due to the development of technologies used to diagnose and treat infectious diseases. Nucleic acid (DNA) probes are used for the detection of bacterial and fungal infections and viral diagnosis. The DNA probe test market will continue to grow in this segment due to the development of in-situ hybridization with non-isotopic DNA probes. These probes help in the detection of human papillomavirus in cellular material.
DNA probe-based diagnostic market by geography
The presence of key vendors such as Abbott and Roche in the Americas is driving the growth prospects for the DNA probe-based diagnostic market in the forthcoming years. The demand and adoption of DNA genetic testing and DNA probe-based diagnostic techniques will continue to increase in the region throughout the predicted period due to the rising incidence of diseases such as cancer and the growing need for molecular diagnosis of such diseases.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global DNA probe-based diagnostic market?
- What are the key market trends impacting the growth of the global DNA probe-based diagnostic market?
- What are the challenges to market growth?
- Who are the key vendors in the global DNA probe-based diagnostic market?
- What are the market opportunities and threats faced by the vendors in the global DNA probe-based diagnostic market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global DNA probe-based diagnostic market?
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MARKET LANDSCAPE
- Market size and forecast
- Five forces analysis
PART 06: MARKET SEGMENTATION BY APPLICATION
- Global DNA probe-based diagnostics market by application
- Global DNA probe-based diagnostics market by infectious disease testing
- Global DNA probe-based diagnostics market by cancer testing
- Global DNA probe-based diagnostics market by others
PART 07: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- DNA probe-based diagnostics market in Americas
- DNA probe-based diagnostics market in EMEA
- DNA probe-based diagnostics market in APAC
- Market opportunity
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 10: MARKET TRENDS
- Advancement in DNA array
- Increase in molecular research activities
- Increasing importance of promotional activities
- Increasing prominence of DNA probe technology in diagnosing vaginitis
PART 11: VENDOR LANDSCAPE
- Competitive scenario
- Investment opportunity
PART 12: KEY VENDOR ANALYSIS
- Abbott Laboratories
- F. Hoffmann La Roche
- GE Healthcare
- Thermo Fisher Scientific
- Other prominent vendors
PART 13: APPENDIX